APEX Ventures

Quibim is a global leader in whole-body medical imaging analysis headquartered in Valencia, Spain. Its platform, Quibim Precision, provides an AI-first ecosystem that standardizes imaging quality, automates feature extraction, and delivers quantitative imaging biomarkers across all body parts and modalities. The system integrates deep‑learning, radiomics, and multi‑omics data to enhance disease detection, support clinical trials, and monitor treatment efficacy for pharmaceutical companies and research teams worldwide.

Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.

HyperHeat develops advanced electric heating solutions capable of reaching temperatures up to 2000°C. Utilizing renewable electricity, HyperHeat provides an efficient alternative to fossil fuels for industries like steel, cement, and chemicals. With a high efficiency rate and scalability, the technology offers significant CO2 emission reductions.

GEMESYS, a German tech company, specializes in developing advanced AI chips. Founded as a spin-off from Ruhr-University Bochum, the company leverages memristors, novel electronic components, to create highly efficient neural network processing systems. Their technology enables on-device AI training and inference, opening up new possibilities for Edge AI applications.

TriLite Technologies specializes in manufacturing ultra-small RGB laser beam scanners. Its products are designed for use in augmented reality/mixed reality/virtual reality head-mounted devices, head-up displays, pico projectors, and smart home applications.

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

Senisca is a senotherapeutics company established in 2020, focused on developing anti-aging oligonucleotide therapeutics. The company aims to provide innovative pharmaceutical treatments for age-related chronic diseases by creating a new generation of oligonucleotide-based interventions. These therapeutics target the underlying mechanisms of aging, restoring the ability of cells to regulate gene expression effectively. By rejuvenating aged cells, Senisca seeks to improve healthspan and address both the diseases and aesthetic manifestations of aging, ultimately enabling individuals to live healthier for longer periods.

Zetta Genomics is a company based in Cambridge, England, founded in 2018, that focuses on managing large-scale genomic data for precision medicine. It operates a user-centric platform that facilitates direct connections between individuals and researchers, allowing users to share their personal health and genomic data. This platform supports research into a range of common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. Zetta Genomics enables individuals to participate in studies with the choice to opt in or out, ensuring they have transparency and control over their data. The company utilizes distributed database technology and adheres to strict security practices to maximize the benefits of genomic data while maintaining data privacy.

Solvemed Limited stands at the forefront of innovation in neurological care, leveraging advanced AI technology to pioneer precision diagnostics and personalized treatment recommendations. Our cutting-edge solutions empower healthcare professionals with unprecedented insights, enabling early detection and monitoring of neurological disorders such as Parkinson's disease. With a steadfast commitment to improving patient outcomes, we seamlessly integrate our AI-driven platform to revolutionize the landscape of neurology diagnostics and drug discovery. Backed by a dedicated team of experts and powered by state-of-the-art technology, Solvemed Limited remains steadfast in its mission to redefine the standards of neurological care worldwide.

sewts GmbH, founded in 2019 and located in Munich, Germany, specializes in automation technology focused on the processing of easily deformable materials, particularly textiles. The company collaborates with the Technical University of Munich to create finite element (FE) simulations that accurately replicate textile behavior. Its flagship product, Velum, is an AI-driven technology that analyzes textiles and converts insights into robotic commands. This innovative solution supports real-time motion and trajectory planning, enabling efficient control of industrial robots and coordination among multiple robots. sewts' technology streamlines complex manual processes in industrial settings, such as laundries and garment manufacturing, while promoting sustainability and innovation in production methods. The company is supported by several investors, including APEX Ventures and Bayern Kapital, which underscores its commitment to advancing the robotics and textile industries.

Upfront Diagnostics specializes in the development of rapid diagnostic tests for stroke identification using blood biomarkers. Their innovative approach enables emergency medical professionals to detect large vessel occlusion strokes within minutes, leading to faster and more accurate diagnoses, improved patient outcomes, and reduced healthcare costs.

Zetta Genomics is a company based in Cambridge, England, founded in 2018, that focuses on managing large-scale genomic data for precision medicine. It operates a user-centric platform that facilitates direct connections between individuals and researchers, allowing users to share their personal health and genomic data. This platform supports research into a range of common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. Zetta Genomics enables individuals to participate in studies with the choice to opt in or out, ensuring they have transparency and control over their data. The company utilizes distributed database technology and adheres to strict security practices to maximize the benefits of genomic data while maintaining data privacy.

Planqc develops advanced quantum computers that store and process information using individual atoms as qubits. Their unique approach involves arranging these qubits in scalable arrays and manipulating them with precise laser pulses, aiming to achieve industry-relevant quantum advantage.

Refined Laser Systems is a specialized manufacturer of biophotonics devices, focusing on stain-free tissue diagnostics using its proprietary fiber-based tunable picosecond laser technology. The company's innovative laser systems enable rapid and reliable diagnoses, significantly reducing the time required compared to traditional methods.

Founded in 2018, OroraTech is a global intelligence-as-a-service company based in Munich, Germany. It specializes in thermal data analysis for sustainable Earth monitoring, with operations in Canada and Brazil. The company's core product, Wildfire Solution, uses proprietary space-based sensors to detect fires of any scale day or night, providing real-time situational awareness and prompt risk alerts. OroraTech's team of over 100 experts is committed to delivering innovative solutions for a sustainable future.

Solvemed Group leverages proprietary machine learning technology to develop digital biomarkers for accurate, early diagnostics and monitoring of neurological conditions, initially focusing on Parkinson's disease. Collaborating with leading research institutions, the company aims to improve patient care and revolutionize drug discovery.

Lyfegen is a global, independent provider of drug access, pricing and rebate management solutions, headquartered in Basel, Switzerland, with offices in Boston, USA. The company offers software and services to help healthcare payers and pharmaceutical companies identify appropriate price agreements, simulate and understand the financial impact of those agreements, and automate the execution and adjudication of rebates, reducing administrative effort. By enabling more efficient rebate management, Lyfegen aims to improve patient access to therapies, affordability, and overall health outcomes.

CardiaTec is a digital biotechnology company focused on revolutionizing cardiovascular drug discovery through the integration of artificial intelligence and specialized expertise. The company aims to transform the understanding of cardiovascular disease by developing AI-driven platforms for target identification and novel drug discovery. This approach seeks to provide effective therapeutics for cardiovascular diseases, addressing significant gaps in diagnostics, patient stratification, and treatment options for conditions such as coronary artery disease. By leveraging advanced technology and scientific knowledge, CardiaTec is dedicated to improving healthcare outcomes related to cardiovascular health.

OKAPI:Orbits provides an AI-powered space traffic management platform that predicts collision risks, manages conjunctions, and optimizes satellite operations to enable safer, more efficient use of crowded orbits. The platform includes environment visualization, maneuver design, conjunction analysis, re-entry predictions, high-accuracy orbit propagation and determination, and pass prediction, with secure ground-segment integration for space operators and institutions. The company aims to support sustainable space activity by reducing collision risk and enabling reliable operations in increasingly congested space.

Senisca is a senotherapeutics company established in 2020, focused on developing anti-aging oligonucleotide therapeutics. The company aims to provide innovative pharmaceutical treatments for age-related chronic diseases by creating a new generation of oligonucleotide-based interventions. These therapeutics target the underlying mechanisms of aging, restoring the ability of cells to regulate gene expression effectively. By rejuvenating aged cells, Senisca seeks to improve healthspan and address both the diseases and aesthetic manifestations of aging, ultimately enabling individuals to live healthier for longer periods.

Founded in Berlin, Germany in 2019, Elucidate develops a platform for managing financial crime risks. Its core product, the Elucidate FinCrime Index (EFI), uses probabilistic modeling and machine learning to assess risk levels for financial institutions.

Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

Zetta Genomics is a company based in Cambridge, England, founded in 2018, that focuses on managing large-scale genomic data for precision medicine. It operates a user-centric platform that facilitates direct connections between individuals and researchers, allowing users to share their personal health and genomic data. This platform supports research into a range of common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. Zetta Genomics enables individuals to participate in studies with the choice to opt in or out, ensuring they have transparency and control over their data. The company utilizes distributed database technology and adheres to strict security practices to maximize the benefits of genomic data while maintaining data privacy.

Morpher is a blockchain trading platform that aims to democratize trading by enabling users to trade various assets, including stocks, commodities, and currencies, without any fees and with infinite liquidity. Utilizing the Ethereum blockchain, Morpher replaces traditional intermediaries such as banks and brokers with its decentralized protocol. Users can stake the platform's native token on the price movements of different markets, allowing for a unique trading experience that includes the ability to short assets and trade with leverage. The platform operates 24/7, providing users with continuous access to markets, and is capable of creating new trading opportunities for assets not typically available through conventional channels.

Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the development of refrigeration solutions, particularly for cryogen-free cooling applications. The company focuses on providing easy-to-use, turn-key cryostats that facilitate low-temperature investigations of material samples, thereby accelerating the development and testing of quantum hardware and related electronics. Kiutra's innovative cooling platforms achieve continuous sub-Kelvin temperatures without relying on liquid cooling media, such as helium-3, which is both rare and costly. This technology is essential for enabling cryogenic conditions in a compact and cost-efficient manner, making it applicable for advanced fields like quantum computing, quantum communications, and quantum sensing. By offering efficient cooling solutions, Kiutra supports research and industry customers in their pursuit of scalable quantum technologies.

TriLite Technologies specializes in manufacturing ultra-small RGB laser beam scanners. Its products are designed for use in augmented reality/mixed reality/virtual reality head-mounted devices, head-up displays, pico projectors, and smart home applications.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

Mobius Labs GmbH is a Berlin-based company founded in 2018 that specializes in developing advanced image and video understanding software. The company offers lightweight computer vision algorithms that can be licensed for integration with various applications, devices, and processes. Its flagship product, Superhuman Vision, utilizes few-shot learning models that allow for easy customization, enabling even non-experts to create new models. These models can operate locally on edge devices with limited processing power and storage, making them both cost-effective and scalable. Mobius Labs aims to enhance visual searches by transforming images and videos into actionable insights, thereby providing businesses with the ability to generate automatic metadata and seize new market opportunities.

Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.

Yuri is a company specializing in the design and manufacturing of hardware for the aviation and aerospace industry. It offers a comprehensive range of services aimed at supporting microgravity research and experiments. These services encompass mission definition, hardware selection and development, as well as launch and return logistics. In addition to its focus on space missions, Yuri is involved in various scientific research areas, including growing cell cultures in 3D, modeling human diseases, analyzing proteins and molecules, synthetic biology, studying plant biology, and nanofluidics. This diverse expertise positions Yuri as a key player in advancing research capabilities within the aerospace sector.

Founded in 2018, OroraTech is a global intelligence-as-a-service company based in Munich, Germany. It specializes in thermal data analysis for sustainable Earth monitoring, with operations in Canada and Brazil. The company's core product, Wildfire Solution, uses proprietary space-based sensors to detect fires of any scale day or night, providing real-time situational awareness and prompt risk alerts. OroraTech's team of over 100 experts is committed to delivering innovative solutions for a sustainable future.

VitreaLab develops laser-powered photonic backlighting technology for displays. The company designs and manufactures photonic integrated circuits and light sources that replace conventional LCD backlighting, delivering dedicated light per sub-pixel with precise color, polarization, and angular distribution. Its approach uses glass-based waveguides to control and route light at microscopic scales, enabling higher energy efficiency, improved brightness and contrast, and richer color rendering. The core objective is to unlock augmented reality, virtual reality, and 3D displays by delivering laser-powered illumination without goggles. Founded in 2018 and headquartered in Vienna, VitreaLab focuses on transforming display technology for everyday use.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

sewts GmbH, founded in 2019 and located in Munich, Germany, specializes in automation technology focused on the processing of easily deformable materials, particularly textiles. The company collaborates with the Technical University of Munich to create finite element (FE) simulations that accurately replicate textile behavior. Its flagship product, Velum, is an AI-driven technology that analyzes textiles and converts insights into robotic commands. This innovative solution supports real-time motion and trajectory planning, enabling efficient control of industrial robots and coordination among multiple robots. sewts' technology streamlines complex manual processes in industrial settings, such as laundries and garment manufacturing, while promoting sustainability and innovation in production methods. The company is supported by several investors, including APEX Ventures and Bayern Kapital, which underscores its commitment to advancing the robotics and textile industries.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Founded in Berlin, Germany in 2019, Elucidate develops a platform for managing financial crime risks. Its core product, the Elucidate FinCrime Index (EFI), uses probabilistic modeling and machine learning to assess risk levels for financial institutions.

Phantasma Labs Limited is a London-based company founded in 2018 that specializes in developing a simulation platform aimed at enhancing the training of autonomous vehicles. The company focuses on creating crucial data sets and models of human behavior to improve the understanding of self-driving cars in various scenarios, particularly in extreme situations. By immersing real humans in virtual environments, Phantasma Labs enables artificial intelligence systems to learn from realistic interactions with pedestrians, cyclists, and other road users. This innovative approach facilitates the generation of large-scale data sets that simulate real-life conditions, allowing clients to benefit from advanced decision support without the need for extensive big data. Through its technology, Phantasma Labs contributes to safer and more effective autonomous vehicle operations by training AI to navigate complex human behaviors.

Morpher is a blockchain trading platform that aims to democratize trading by enabling users to trade various assets, including stocks, commodities, and currencies, without any fees and with infinite liquidity. Utilizing the Ethereum blockchain, Morpher replaces traditional intermediaries such as banks and brokers with its decentralized protocol. Users can stake the platform's native token on the price movements of different markets, allowing for a unique trading experience that includes the ability to short assets and trade with leverage. The platform operates 24/7, providing users with continuous access to markets, and is capable of creating new trading opportunities for assets not typically available through conventional channels.

Novoic develops an AI-driven speech analytics platform designed for clinical use. It enables healthcare professionals to identify and track changes in speech patterns associated with neurological diseases, particularly early signs of dementia.

Quibim is a global leader in whole-body medical imaging analysis headquartered in Valencia, Spain. Its platform, Quibim Precision, provides an AI-first ecosystem that standardizes imaging quality, automates feature extraction, and delivers quantitative imaging biomarkers across all body parts and modalities. The system integrates deep‑learning, radiomics, and multi‑omics data to enhance disease detection, support clinical trials, and monitor treatment efficacy for pharmaceutical companies and research teams worldwide.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Founded in Berlin, Germany in 2019, Elucidate develops a platform for managing financial crime risks. Its core product, the Elucidate FinCrime Index (EFI), uses probabilistic modeling and machine learning to assess risk levels for financial institutions.

TriLite Technologies specializes in manufacturing ultra-small RGB laser beam scanners. Its products are designed for use in augmented reality/mixed reality/virtual reality head-mounted devices, head-up displays, pico projectors, and smart home applications.

VitreaLab develops laser-powered photonic backlighting technology for displays. The company designs and manufactures photonic integrated circuits and light sources that replace conventional LCD backlighting, delivering dedicated light per sub-pixel with precise color, polarization, and angular distribution. Its approach uses glass-based waveguides to control and route light at microscopic scales, enabling higher energy efficiency, improved brightness and contrast, and richer color rendering. The core objective is to unlock augmented reality, virtual reality, and 3D displays by delivering laser-powered illumination without goggles. Founded in 2018 and headquartered in Vienna, VitreaLab focuses on transforming display technology for everyday use.

MindPeak GmbH is a technology company based in Hamburg, Germany, founded in 2018. It specializes in developing artificial intelligence software tools aimed at enhancing the accuracy and efficiency of cancer diagnostics. The company's flagship product, BreastAI, is designed for the quantification of breast cancer immunohistochemistry (IHC) and can be integrated into third-party software systems. MindPeak's solutions automate tissue diagnostics, enabling pathologists to identify and quantify tumorous regions and detect breast cancer cells more effectively. By streamlining tasks such as cell and biomarker quantification, MindPeak's tools allow cancer specialists to focus on critical decision-making in clinical environments, ultimately improving patient care while making diagnostic processes more accessible and cost-effective.

Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the development of refrigeration solutions, particularly for cryogen-free cooling applications. The company focuses on providing easy-to-use, turn-key cryostats that facilitate low-temperature investigations of material samples, thereby accelerating the development and testing of quantum hardware and related electronics. Kiutra's innovative cooling platforms achieve continuous sub-Kelvin temperatures without relying on liquid cooling media, such as helium-3, which is both rare and costly. This technology is essential for enabling cryogenic conditions in a compact and cost-efficient manner, making it applicable for advanced fields like quantum computing, quantum communications, and quantum sensing. By offering efficient cooling solutions, Kiutra supports research and industry customers in their pursuit of scalable quantum technologies.

Avinew develops AI-driven software solutions for the insurance industry. It specializes in telematics-based programs that detect and measure semi-autonomous and autonomous vehicle features to determine premium discount eligibility.

T3K-Forensics GmbH, founded in 2007 and based in Vienna, Austria, specializes in mobile forensics software and services tailored for law enforcement agencies. The company develops advanced software solutions, including its LEAP product, which analyzes smartphone data and generates comprehensive reports on the content of the devices. T3K-Forensics is committed to enhancing mobile security and provides customized analytics solutions to forensic law enforcement units. In addition to its software offerings, the company also delivers training programs in areas such as mobile phone extraction and analysis, smartphone forensics, and SQLite forensics for smartphones, ensuring that law enforcement professionals are well-equipped to handle mobile data investigations.

Lendflo is a peer-to-peer invoice financing marketplace that utilizes blockchain technology and machine learning to provide small and medium-sized businesses with an efficient and cost-effective financing solution. Founded in 2017 and based in London, the platform aims to simplify the invoice financing process, enabling businesses to access funds more quickly and easily. As of May 2020, Lendflo operates as a subsidiary of ABH Holdings S.A., enhancing its capabilities within the financial technology sector.

ImageBiopsy Lab is a leading developer of AI-based software for image analysis in musculoskeletal (MSK) radiology, orthopedic surgery, and traumatology. The company has created an advanced platform that automates the reading and prioritization of low-risk, low-reimbursement plain film MSK X-rays, thereby optimizing physician resources and minimizing manual reporting. ImageBiopsy Lab aims to address all clinically relevant MSK and orthopedic use cases, extending its capabilities from basic X-rays to more complex MRI and CT scans. To enhance its technology, the company collaborates with prominent medical institutions across the US and Europe, facilitating access to extensive training data and expert annotations. With offices in both regions, ImageBiopsy Lab is advancing its suite of AI modules, which are currently undergoing FDA and CE certification processes, to cover a wide array of common MSK-X-ray applications. The platform is designed to improve the early detection of musculoskeletal diseases, ultimately enabling patients to receive more precisely targeted and affordable therapies.

Mobius Labs GmbH is a Berlin-based company founded in 2018 that specializes in developing advanced image and video understanding software. The company offers lightweight computer vision algorithms that can be licensed for integration with various applications, devices, and processes. Its flagship product, Superhuman Vision, utilizes few-shot learning models that allow for easy customization, enabling even non-experts to create new models. These models can operate locally on edge devices with limited processing power and storage, making them both cost-effective and scalable. Mobius Labs aims to enhance visual searches by transforming images and videos into actionable insights, thereby providing businesses with the ability to generate automatic metadata and seize new market opportunities.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

Founded in 2017, HAAWK is a media services company based in Studio City, California. It specializes in managing and monetizing the copyrights of independent music, film, and television catalogs. The company offers rights management, copyright enforcement, music distribution, and micro-sync licensing services.

Founded in Austria in 2016, Kivu Technologies is a multidisciplinary team of professionals dedicated to driving innovation through technology. They specialize in designing and building analytical software to combat terrorism and enhance global security.